Astria Therapeutics, Inc.

Historical 13F Holders

Symbol
ATXS
CUSIP
04635X102
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 04635X102 since 12/18/2024, largest first.

Filer % of Class Filed
Glazer Capital, LLC 13G/A
6.6% 2/12/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (9)
Venrock Healthcare Capital Partners III, L.P. 13G/A
4.4% 2/14/2025
Event 12/31/2024
Fairmount Funds Management LLC 13G/A
4.0% 10/15/2025
Event 10/14/2025
FMR LLC 13G/A
2.2% 11/7/2025
Event 10/31/2025
Integrated Core Strategies (US) LLC 13G/A
0.4% 10/20/2025
Event 10/14/2025
ForGrowth III PA B.V. 13G/A
0% 11/14/2025
Event 10/16/2025
Magnetar Financial LLC 13D/A
0% 1/28/2026
Event 1/26/2026
Perceptive Advisors LLC 13D/A
0% 2/9/2026
Event 1/26/2026
RA Capital Management, L.P. 13G/A
0% 8/14/2025
Event 6/30/2025
Vestal Point Capital, LP 13G/A
0% 2/17/2026
Event 12/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q4 141 56.5 M $738M
2025 Q3 116 57.6 M $409M
2025 Q2 107 57.6 M $310M
2025 Q1 117 58.3 M $311M
2024 Q4 112 58.5 M $523M
2024 Q3 104 56.5 M $622M
2024 Q2 101 55.6 M $506M
2024 Q1 108 57.6 M $811M
2023 Q4 82 36.9 M $283M
2023 Q3 69 23.0 M $171M
2023 Q2 77 24.7 M $205M
2023 Q1 67 23.4 M $312M
2022 Q4 62 22.0 M $326M
2022 Q3 44 9.83 M $88.8M
2022 Q2 33 5.73 M $17.2M
2022 Q1 35 6.21 M $41.7M
2021 Q4 35 6.09 M $32.8M
2021 Q3 37 7.21 M $63.8M